Senescence is a cellular phenotype characterized by an irreversible cell cycle arrest and the secretion of inflammatory proteins, denominated senescence-associated secretory phenotype (SASP). The SASP is important in influencing the behavior of neighboring cells and altering the microenvironment; yet, until now this role has been mainly attributed to soluble factors. Here, we report that extracellular vesicles also alter the environment by transmitting the senescent phenotype to other cells via exosomes (extracellular vesicles of endocytic origin). A combination of functional assays, Cre-loxP reporter systems, proteomic analysis and RNAi screens confirm that exosomes form part of the senescent secretome and mediate paracrine senescence via the activation of a non-canonical interferon (IFN) pathway. Altogether, we speculate that exosomes could be drivers of tissue degeneration both locally and systemically during aging and agerelated disease.
SUMMARY
Senescence is a cellular phenotype characterized by an irreversible cell cycle arrest and the secretion of inflammatory proteins, denominated senescence-associated secretory phenotype (SASP). The SASP is important in influencing the behavior of neighboring cells and altering the microenvironment; yet, until now this role has been mainly attributed to soluble factors. Here, we report that extracellular vesicles also alter the environment by transmitting the senescent phenotype to other cells via exosomes (extracellular vesicles of endocytic origin). A combination of functional assays, Cre-loxP reporter systems, proteomic analysis and RNAi screens confirm that exosomes form part of the senescent secretome and mediate paracrine senescence via the activation of a non-canonical interferon (IFN) pathway. Altogether, we speculate that exosomes could be drivers of tissue degeneration both locally and systemically during aging and agerelated disease.
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INTRODUCTION
The establishment of cellular senescence is categorized by an irreversible cell cycle arrest and the capacity to modify the microenvironment through a particular secretome named SASP (senescence-associated secretory phenotype). The activation of senescence is a response to different stress triggers in order to prevent the propagation of damaged and has been show to occur in vitro and in vivo. In fact, senescence has been observed in vivo during both biological and pathological processes such as development, cancer, fibrosis and wound healing (He and Sharpless, 2017; Munoz-Espin and Serrano, 2014) . The SASP controls its surroundings by reinforcing senescence in an autocrine (cell autonomous) and paracrine (non-cell autonomous) manner, by recruiting immune cells to eliminate senescent cells and by inducing a stem-cell like phenotype in damaged cells (Mosteiro et al., 2016; Salama et al., 2014) . Altogether, the SASP provides the necessary balance to restore tissue homeostasis when it has been compromised. Paradoxically, the SASP can also contribute to enhance tissue damage, but the mechanisms behind this pleiotropic activity of the SASP are not well understood.
Most studies in vitro and in vivo have attributed the diverse functions of the SASP to individual protein components such as IL-6 or IL-8 to reinforce autocrine senescence (Acosta et al., 2008; Kuilman et al., 2008) or TGF-b as the main mediator of paracrine senescence (Acosta et al., 2013; Rapisarda et al., 2017) or to a dynamic SASP with TGF-b or IL-6 as predominant individual components (Hoare et al., 2016) . However, it is still unclear how these diverse SASP components regulate senescence. In fact, inhibition of the SASP by block the mammalian target of rapamycin (mTOR) only partially blocks the SASP, suggesting that alternative mechanisms might exist (Herranz et al., 2015; Laberge et al., 2015) .
Exosomes are small extracellular vesicles (30-120 nm) of endocytic origin secreted by all cell types and therefore found in most bodily fluids. Exosomes contain nucleic acids, proteins and lipids that generally reflect the status of the parental cell and can influence the behavior of recipient cells locally and systemically (Tkach and Thery, 2016) . In fact, the increasing literature regarding exosomes show that they can be used as disease biomarkers (Melo et al., 2015) , indicators of cancer metastatic predisposition (Hoshino et al., 2015) or as therapeutic carrier vesicles (Kamerkar et al., 2017) . However, although some studies have found an increase in the number of exosomes released during senescence (Lehmann et al., 2008; Takasugi et al., 2017) , very little is known regarding the role that exosomes play as SASP mediators in the microenvironment.
Here, our data show that inhibition of exosome biogenesis prevents the induction of senescence in neighboring cells and that both the soluble and exosome fraction are capable of transmitting senescence. Furthermore, the analysis of the individual cells internalizing exosomes, show a direct link between the uptake of exosomes derived from senescent cells and paracrine senescence induction. We also show that exosome biogenesis is an essential cellular process. Interestingly, exosome protein characterization by Mass Spectrometry (MS) followed by a functional siRNA screen identify the non-classical interferon (IFN) pathway as responsible for transmitting senescence to normal cells.
RESULTS

Blocking exosome biogenesis prevents the paracrine induction of senescence
In order to investigate whether exosomes act as intercellular mediators in neighboring cells during senescence, we took advantage of HFFF2 human foreskin primary fibroblasts expressing a chimeric fusion protein (ER) with either an empty vector (ER: (Hannun and Obeid, 2008; Trajkovic et al., 2008) , prevents this proliferation arrest ( Figure 1B-left graph) . Torin-2, an mTOR inhibitor previously described to suppress the SASP (Herranz et al., 2015; Laberge et al., 2015) also prevented paracrine senescence ( Figure 1B ). It has been described that blocking exosome biogenesis induces a DNAdamage response (Takahashi et al., 2017) , so next we decided to determine the levels of phosphorylated-gH2AX (p-gH2AX), which is also a marker of senescence, by immunofluorescence (IF). To our surprise, the levels of p-gH2AX also decreased when both GW4869 and SpE were used and also upon the use of Torin-2 ( Figure 1B -right graph). To further confirm the implication of exosomes on transmitting senescence, we used a non-targeting small interfering RNA (siRNA) (Scr) and two siRNA targeting two canonical regulators of exosome secretion, RAB27A (siRAB27A #3,#4) (Ostrowski et al., 2010) and Synaptotagmin-7 (siSYT7 #1,#2) (Hoshino et al., 2013) (Figure S1B ,C). Our data show that iRAS transfected with siRAB27A and siSYT7 prevented exosome release ( Figure S1C ) and therefore their CM did not induce growth arrest nor DNA-damage ( Figure 1C) . We also analyzed the expression levels of additional markers of senescence by IF such as p21 CIP ( Figure S1D ,E) and p53 (not shown). A similar response was observed in an additional strain of fibroblasts, IMR-90, by measuring the levels of expression of p21 CIP by IF ( Figure S1F ) and p-gH2AX (not shown). Next, we used Transwell inserts with 0.4 µm pore membranes to avoid the transfer of larger vesicles, plating iC and iRAS with the different treatments in the upper chamber (UC) and later plating HFFF2 in the lower chamber (LC) with fresh CM ( Figure 1D ). As per our previous data, we could observe that treatment with GW4869 (10µM) and SpE (5µM) prevented paracrine senescence in a similar fashion to Torin-2 (50nM), observed by a reduction in the cells incorporating BrdU and the expression levels of p16 INK4A ( Figure 1E , Figure S1G ). Altogether, our data suggest that exosome release could be implicated in inducing paracrine senescence.
Exosomes derived from iRAS cells are responsible for mediating paracrine senescence
In order to confirm that exosomes are responsible for inducing paracrine senescence we decided to dissect the CM from iC and iRAS HFFF2s and compared the role of large 
Exosomes isolated from iRAS induce a cell cycle arrest in HFFFs
To identify the pathways regulated upon exosome treatment, we decided to perform RNA sequencing of HFFF2s incubated with exosomes derived from iRAS and from HFFF2 treated with 50µM Etoposide for 48h followed by 5 days incubation with fresh medium (mimicking DNA-damage induced senescence; DDIS) ( Figure 2E ). Gene ontology (GO) analysis of genes deregulated by > 2 log 2 fold difference expression levels and p-value < 0.05 in both OIS-and DDIS-exosome treated HFFF2s, confirmed a shared "Cell cycle"
and "Cell proliferation" signature ( Figure 2E,F) , with the "p53 signaling pathway' being over-represented ( Figure S2F ). In fact, HFFF2s treated with an equal number of control and DDIS-derived exosomes show an increase in the mRNA expression levels of the cell cycle regulators, CDKN1A, CDKN2A, by qPCR and p53 protein levels by IF ( Figure   2G ,H), while SpE prevented this upregulation ( Figure 2G,H) . Similar results were obtained in HFFF2 treated with exosomes derived from iRAS cells treated with and without SpE ( Figure S2G ). These data indicate that the inhibition of exosome biogenesis alters the content of exosomes during senescence, suggesting a specific cargo loading exists during senescence independent of exosome number.
The uptake of exosomes derived from senescent cells induces paracrine senescence
Next, we decided to investigate whether exosomes from both iC and iRAS cells were being internalized by HFFF2. For this we generated iRAS HFFF2 cells expressing a mCherry-CD63 construct (iRAS;CD63-ch), which release mCherry positive exosomes (CD63-ex), and HFFF2s expressing GFP (GFP). First, we decided to co-culture both GFP + and iRAS;CD63-ch + cells in a 1:1 ratio with 200nM 4OHT for 2 days followed by replenishing with fresh media for 4 days ( Figure 3A ) and determine the presence of CD63-ex transfer in GFP + HFFF2s by confocal microscopy ( Figure S3A ) and the super resolution Airyscan microscope ( Figure 3B ). In fact, using both techniques we could observe CD63-ex transfer within GFP + HFFF2s ( Figure 3B, Figure S3A) . Furthermore, as shown in Figure 3B , 3D rotation of a Z-stack image shows internalized CD63-ex. In order to avoid confounding effects of the SASP, we next purified CD63-ex from iRAS;CD63-ch and iC;CD63-ch cells and treated normal unlabeled HFFF2 cells ( Figure   3C ). Figure 3C ; right panel). These data suggest that exosomes derived from iRAS are the cause of paracrine senescence in HFFF2s.
Cre-loxP reporter system confirms a direct link between exosome uptake and induction of senescence
To further confirm a direct role for exosomes derived from senescent cells in inducing paracrine senescence, we next used the Cre loxP reporter system previously described (Zomer et al., 2015; Zomer et al., 2016) . For this, we generated MCF7 breast cancer and Sudan Black + cells, which stains for lysosomal aggregates, a characteristic of senescence (Georgakopoulou et al., 2013) (Figure 3E ). In fact, in Figure 3F we show that the percentage of GFP + /Sudan Black + cells is higher upon treatment with Cre-ex isolated from Palbo-treated MCF7s. Additionally, we could observe that GFP + cells were negative for Ki67 when treated with Cre-ex derived from Palbo treated cells ( Figure 3G) and that the percentage of GFP + /Ki67 + cells decreased upon treatment with Palboderived Cre-ex ( Figure 3H ). Altogether, these data confirm that exosomes derived from senescent cells are indeed the direct cause of paracrine senescence induction.
Human and ex vivo mouse cells undergoing senescence secrete more exosomes
Previous studies have shown that cells undergoing senescence release more exosomes (Kavanagh et al., 2017; Lehmann et al., 2008; Takasugi et al., 2017) . 
Exosome biogenesis is an essential feature of senescent cells
Next, we wanted to ask if exosome biogenesis is an essential process during senescence. To test this, we treated iRAS HFFF2 with SpE and GW4869 and determined whether blocking exosome biogenesis affected senescence. To our surprise and in contrast with published data (Kavanagh et al., 2017; Takahashi et al., 2017) , blocking exosome biogenesis prevented the establishment of senescence as shown by a partial reversion in the percentage of HFFF2s incorporating BrdU ( Figure 4C ) and a reduction in the levels of p-gH2AX positive HFFF2 by IF (Figure S4D,E) . Furthermore, qPCR analysis to determine the mRNA levels of additional markers of senescence also show a partial reduction in the upregulation of IL6, IL8, IL1A, CDKN2A and CDKN1A when iRAS cells were treated with either SpE or GW4869 ( Figure 4D , Figure S4F ). We also observed that the use of two independent siRAB27A and siSYT7 prevented the cell cycle arrest characteristic of senescence ( Figure 4E ). In fact, iRAS HFFF2 expressing a vector encoding for two previously characterized short hairpin RNA targeting p53 (shp53) and p16 INK4A (shp16) (Acosta et al., 2008; Rapisarda et al., 2017) show a reduction in the release of exosomes when RAS is expressed (+ 4OHT) ( Figure S4G) . Importantly, the simultaneous use of inhibitors of the SASP (Torin-2) and inhibitors of exosome biogenesis (SpE or GW4869) induced cell death in HFFFs as shown by nuclear staining of the apoptosis marker Annexin V ( Figure 4F ) suggesting that both pathways are equally essential for the successful establishment of the senescence program in primary fibroblasts. These data show that blocking exosome biogenesis partially prevents the induction of senescence in HFFF2 cells.
Exosome protein cargo is responsible for inducing paracrine senescence
Based on our previous finding, we hypothesized that the protein content of the exosomes derived from control and senescent HFFF2s might differ. For this, we subjected purified exosomes from iRAS and Etop-treated HFFF2 and their respective controls to label-free mass spectrometry (MS) analysis ( Figure 5A ). GO analysis of the 1600 proteins identified show the Cellular component "Extracellular exosome" is overrepresented ( Figure 5B ). To identify proteins exclusively regulating senescence, we selected proteins deregulated in both OIS-and DDIS-exosomes vs control exosomes with > 2 log 2 fold change difference and adjusted false discovery rate (FDR) < 0.01 in both OIS and DDIS.
The Venn diagram analysis shows that 265 proteins are deregulated during both OIS and DDIS ( Figure 5C ), which group into GO Biological Processes related to senescence, as "Wound healing" and "Cell adhesion" ( Figure 5D ). Furthermore, volcano plot analysis comparing individually OIS-and DDIS-exosomes protein vs their respective controls
show that most proteins identified within exosomes derived from senescent HFFF2s are upregulated ( Figure S5A ). To determine which of these proteins are essential to mediate paracrine senescence, we conducted a small-scale screen using siRNA SMART pool in iRAS cells for the top 50 proteins most upregulated in both DDIS and OIS (>2 log 2 fold change; p<0.05; > 4 peptides fold difference between control and senescence) ( Figure   S5B ). We used the CM from iRAS to determine paracrine senescence in normal HFFF2
( Figure 5E ) using siRAB27A and siSYT7 as positive controls (green bars) and determined BrdU incorporation and p21 CIP protein levels by IF ( Figure 5F ; Figure S5C ).
The most consistent candidates preventing both growth arrest and upregulation of p21 Non-cell autonomous (paracrine) senescence via the SASP has been previously described as an important mechanism for the clearance of senescent cells by the immune system (Acosta et al., 2013; Dou et al., 2017; Hoare et al., 2016) , although these studies do not discern between the effect of soluble factors and EVs. Here, we are providing evidence that both the soluble fraction and exosomes are responsible in mediating paracrine senescence. We show not only that blocking exosome biogenesis using small molecule inhibitors and RNAi prevent the induction of senescence but that treatment of normal fibroblasts and cancer cells with exosomes-derived from senescent cells using a variety of stimuli induce senescence. Furthermore, we observe a direct correlation between exosome-uptake and senescence activation in different cell lines with two independent triggers of senescence. Altogether, we demonstrate that exosomes are responsible for mediating paracrine senescence and speculate they play an important role in inducing bystander senescence in therapy-induced senescence (Demaria et al., 2017) , or in mediating bystander aging (Acosta et al., 2013; Nelson et al., 2012) . In fact, when compared to soluble factors, exosomes have very different biophysical and biochemical properties. Exosomes have a longer-lifespan than soluble factors as they are more resistant to protease degradation and can mediate both local and systemic signaling (O'Loghlen, 2018) . Interestingly, in the luciferase knock-in mouse model (p16 LUC ) activation of p16Ink4a + cells was observed not only in emerging neoplasias, but also in the nearby stroma, suggesting that senescence can be transmitted via non-autonomous mechanisms (Burd et al., 2013) . This leads us to speculate that indeed paracrine senescence mediated by exosomes can be transmitted in vivo, although more functional experiments would be needed to confirm this.
Exosome biogenesis is an important feature of many cells and a recent study has shown its relevance in maintaining cellular homeostasis (Takahashi et al., 2017) . In contrast with our data, the authors show a DNA-damage response upon inhibition of exosome biogenesis, which we only observe when blocking both the release of soluble factors and exosomes, which could be due to different experimental settings. However, a common finding is that fact that most cells undergoing senescence triggered by a variety of stimuli release more exosomes in human and mouse cells (Kavanagh et al., 2017; Lehmann et al., 2008; Takahashi et al., 2017) . In addition, we observed that blocking exosome release with small molecule inhibitors and RNAi prevents the activation of senescence (although to a lesser extent than paracrine signaling), highlighting the importance of this pathway during senescence.
Recently, many studies have found a cellular response characteristic of infectious agents during senescence in the absence of pathogens. For example, it has been show that the SASP is regulated by the inflammasome via IL-1a signaling (Acosta et al., 2013) and by the cGAS-STING (cyclic GMP-AMP synthase linked to stimulator of interferon genes)
pathway (Dou et al., 2017; Gluck et al., 2017; Yang et al., 2017) . Both pathways are induced during senescence in the absence of pathogens or in the presence of doublestranded DNA. Here, we show that the non-canonical IFN pathway (Diamond and Farzan, 2013; Platanias, 2005) is being activated by exosomes derived from senescent cells in the absence of pathogens, as we don't observe differences in IFNg secretion between iC or iRAS nor detect IFN or IFNR within exosomes by MS analysis. In fact, HFFF2 treated with exosomes derived from iRAS upregulate IFITM and IFIT transcripts without significant changes in IFN and IFNR RNA common to both OIS and DDIS. Interestingly, IFITM3 is found enriched in exosomes derived from iRAS HFFF2s without being affected in the donor cells undergoing senescence. Finally, blocking the JAK1/2 pathway via small molecule inhibitors, which is activated upon IFN signaling, does not prevent senescence mediated by exosomes. This is not an unprecedent finding, as exosomal RNA from stromal cells has been shown to stimulate the viral RNA pattern recognition receptor (PRR) RIG-I and IFN pathway in the absence of viral RNA (Boelens et al., 2014; Nabet et al., 2017) . However, at present we cannot exclude that DNA/RNA present as cargo or attached to the exosomes are responsible for stimulating IFN signaling, as other reports have found IFN-mediated signaling via exosomes (Cossetti et al., 2014; Li et al., 2013) , a role for IFNAR1 during OIS (Katlinskaya et al., 2016) and DNA from senescent cells secreted via exosomes (Takahashi et al., 2017) .
Although our data exclude a role for microvesicles during senescence, and here we are describing exosomes as a heterogeneous population, it would be interesting for future studies to address whether small extracellular vesicles of endocytic origin or not mediate a similar cellular response in normal cells depending on specific populations (Tkach et al., 2018) .
Finally, the idea that blocking exosome secretion could be a potential therapeutic approach to alleviate senescence "spreading" during senescence-induced by chemotherapy treatment or accumulation in aging tissues presents itself as a very attractive tool in the future. Ki67 was used to determine proliferation. See also Figure S6 .
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EXPERIMENTAL MODELS
Cell culture
HFFF2 human foreskin primary fibroblasts were obtained from the Culture Collections (Public Health England, UK). IMR-90, MCF7 and HEK293T were bought from ATCC.
Breast fibroblasts (BF) were isolated from a breast mastectomy and have been described elsewhere (Rapisarda et al., 2017) . All cells were grown in high glucose Dulbecco's modified Eagle's medium with 10% fetal bovine serum and 1% antibiotic-antimycotic solution. Mouse hepatic stellate cells were a kind gift from Scott Lowe and were grown in 1µg/ml of Doxycycline.
METHOD DETAILS Soluble fraction, exosome and microvesicles isolation
All cells were maintained in exosome-depleted FBS. FBS was depleted of exosomes by overnight ultracentrifugation at 100,000 g at 4°C (Sorvall 100SE Ultracentrifuge). The supernatant was removed and stored in 50 mL falcons at -20°C until required. All CM was collected after 72 h incubation with cells. Whole CM was centrifuged at low speed to eliminate dead cell and cellular debris prior to use.
To isolate exosomes, the protocol of differential ultracentrifugation (Thery et al., 2006) was modified and adapted. The CM was filtered through a 0.22 µm filter prior to the 100,000g centrifugation step and also after in some cases (for the Cre-LoxP experiments). MV were collected after the 10,000g centrifugation step. The supernatant of the CM was collected after the 100,000g centrifugation step and concentrated using a 10K column (Amicon™ Ultra-0.5 Filter). The final 100,000 g pellet was washed twice in 15 ml of PBS and resuspended in 100 µl of sterile DMEM for the functional cell culture experiments. Alternatively, for Western Blot analysis, exosome pellet was re-suspended in protein lysis buffer. A Sorvall 100SE Ultra Centrifuge, with a Beckmann Fixed Angle T865 rotor was used for all exosome isolations.
CM with siRNA and inhibitors functional experiments
24h after plating HFFF2 in 96-well plates, senescence was induced by adding 200nM
4OHT. The following day the cells were washed and supplemented with 0.5% FBS and the indicated inhibitors for 2-3 days, after which plates were washed again to remove the inhibitors from the media and supplemented with fresh media (0.5% FBS) for further 72h.
For the experiments with the siRNA, reverse transfection with 30nM siRNA was performed and the media replenished (10% FBS) with 4OHT after 2 days and left for an additional 48h. After, the cells were washed to remove all siRNA from the media and incubated with 0.5% FBS fresh media for an additional 72h. For the mini-screen 50nM of SMARTPool siRNA was used.
Treatment of cells with CM or isolated exosomes
Fibroblasts were treated with the CM from several experiments previously centrifuged at low speed to discard dead cells and supplemented with FBS to reach 10% in the final volume. HFFF2 treated with isolated exosomes were also supplemented with media containing 10% FBS, while in the experiment performed with MCF the cells were incubated with isolated exosomes resuspended in 0.5% FBS media.
Nanoparticle tracking analysis (NTA)
Prior to the NTA analysis, the NanoSight LM10 equipped with a 405nm laser (Malvern Instruments) was calibrated using Silica Microspheres beads (Polyscience). Samples to be measured were then diluted in PBS in order to obtain a particle number between 10 8 -10 9 particles. At least three repeated measurements of 60s were taken per each individual sample and the mean value was used to determine particle number. Static mode (without flow) was used for each analysis. The movement of each particle in the field of view was measured to generate the average displacement of each particle per unit time which was calculated using the NTA 3.0 software.
Affinity-based capture of exosomes on beads
For exosome characterization by flow cytometry, aldehyde/sulphate latex beads (Thermo Cells grown in 6-well plates or 10 cm dishes were washed with PBS and lysed directly into the culture dish using TRIzol Reagent (Thermo Fisher). cDNA synthesis was performed using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher).
qPCR reactions were performed using SYBR Green PCR Master Mix (Applied Biosystems,) on a 7500 Fast System RealTime PCR cycler (Applied Biosystems). Primer sequences are listed in Table S1 .
Gene expression
Stable retroviral and lentiviral expression was performed as in previous studies (Acosta et al., 2008; Rapisarda et al., 2017) .
Protein analysis by immunoblotting
Exosomes were lysed using the following buffer lysis buffer [(Tris-HCl 20 mM pH 7.6; DTT 1 mM; EDTA 1 mM; PMSF 1 mM; benzamidine 1 mM; sodium molybdate 2 mM; β-sodium glycerophosphate 2 mM; sodium orthovanadate 0.2 mM; KCl 120 mM; 1 μg/ml (each) de leupeptine, pepstatine A and antipaína; NonidetTM P-40 0.5% (v/v); Tritón X-100 0,1% (v/v)], separated in an SDS-PAGE gel, transferred to a PVDF membrane and probed with different antibodies.
RNA sequencing
For RNA-seq, total RNA was extracted using TRIzol Reagent. First strand cDNA synthesis was performed with SuperScript III First-Strand Synthesis System. After purification using SPRI beads, the double stranded cDNA was ligated to in house designed adapters (based on TruSeq Indexed adapters (Illumina)) using NEBNext Ultra II (NEB) followed by 15 cycles of amplification and library purification. Sequencing was performed on an Illumina NextSeq500, High Output run with 75bp paired-end at the Genomics Centre (QMUL).
MS proteomics
LC-MS/MS was done by coupling a nanoLC-Ultra 1D+ system (Eksigent) to an Impact mass spectrometer ( 
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Statistical analysis was performed using Microsoft Excel Software student's t-test.
qPCR gene expression
Ct values were generated using the 7500 software version 2.0.6 (Applied Biosystems).
Relative gene expression was calculated using the ΔΔCt method and normalized to the housekeeping gene RPS14. The relative mRNA expression level changes were expressed as a fold change relative the control.
IF analysis
For IF analysis, all images were analyzed using the IN Cell 2200 Developer software version 1.8 (GE) as previously (Acosta et al., 2008; Rapisarda et al., 2017) .
MS proteomics analysis
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